This study examines the normal postnatal (p.n.) development of the Mongolian gerbil’s vagina from birth to the age when consistent cyclic changes of the estrus occur. At birth, the Müllerian vagina has a lumen and is lined by a pseudostratified or 2- to 3-layered epithelium. The cells contain large amounts of glycogen. The sinus vagina forms a solid plate and contains hardly any glycogen. During the first few p.n. days the cell layers separate, and the newly formed lumen becomes continuous with the Müllerian vagina. Only a vaginal closure membrane persists. Between p.n. days 10 and 15 the epithelium increases in height reaching 2–5 cell layers. The amount of glycogen diminishes, but in the luminal cells the first mucous granules develop. Leukocyte diapedesis starts, and immature Langerhans cells become discernible. Between p.n. days 18 and 30 the apical cells become mucified, and some shedding of these cells begins. Between p.n. days 36 and 45 bundles of keratin filaments appear in many of the luminal mucous cells intermingled with the mucous granules. In the middle layers keratin filaments, keratohyalin granules and membrane-coating granules indicate the beginning of the keratinization process. Diapedesis of leukocytes may lead to cell aggregations below top layers. By day 50 the shedding of the mucous cell layers reveals the underlying keratinized cell layers which then become exfoliated. The first steps of the estrous cycle show a heterogeneous pattern. At about p.n. day 60 the cycle becomes established.

Keywords:
Vaginal epithelium, Postnatal development, Ultrastructure, Mongolian gerbil
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.